The PlanTouch software, developed in partnership with MIM Software Inc erections . PlanTouch has received 510 clearance from the U.S. Food & Medication Administration . PlanTouch’s user interface is completely integrated with the CyberKnife System’s data management and planning software. Doctors is now able to review dose volume histograms, isodose curves, contours, and images and approve treatment plans from their iPads directly. This new mobile remedy can enable improved collaboration between the radiation oncologist and referring physicians, such as thoracic surgeons, neurosurgeons and urologists.

AcelRx completes private keeping common stock AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the advancement and commercialization of innovative treatments for the treating acute and breakthrough pain, announced today that it finished its previously announced personal placement of common share and warrants to purchase common stock on June 1, 2012.0 million. Related StoriesCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyBRCA gene mutations and ovarian cancers: an interview with Dr Matulonis, Harvard Medical SchoolScripps Florida scientists win $2.4 million to expand development of new suffering issued an aggregate of 2 therapiesAcelRx,922,337 newly-issued shares of common stock and warrants to purchase up to 2,630,103 additional shares of common stock..